tbuckley/cabot-search huggingface dataset:
Validation of the EMC92/SKY92 Signature in HOVON-87/Nmsg-18: Gene Expression Based Prognostication Is Applicable in Elderly Patients with Newly Diagnosed Multiple Myeloma
Authors: Mark van Duin, Rowan Kuiper, Martin van Vliet, Annemiek Broijl, Leonie de Best, Erik van Beers, Bronno Van Der Holt, Heleen Visser-Wisselaar, Lizanne Bosman, Belinda Dumee, Fanni van den Bosch, Michael Vermeulen, Jasper Koenders, Marian Stevens-Kroef, Anders Waage, Sonja Zweegman, Pieter Sonneveld
Journal: Blood (2015)
Transfer of Ex Vivo Expanded NK and γδT Cells from Untouched Posttransplant PBMCs to Clear Minimal Residual Disease in Acute Myeloid Leukemia
Authors: Patrick Schlegel, Chihab Klose, Christina Kyzirakos, Ursula J.E. Seidel, Kai Witte, Annika Horrer, Marie Matela, Matthias Pfeiffer, Rupert Handgretinger, Peter Lang
Journal: Blood (2014)
Moxifloxacin Enhances the Antiproliferative and Apoptotic Effects of VP-16 but Inhibits Its Proinflammatory Effects in THP-1 and Jurkat Cells.
Authors: Ina Fabian, Debby Haite, Avital Levitov, Drora Halperin, Itamar Shalit
Journal: Blood (2005)
A Key Role for Tumor Suppressor BTG1 In the Regulation of Metabolic Stress Responses: Implications for Asparaginase Resistance In Pediatric Acute Lymphoblastic Leukemia.
Authors: Laurens van der Meer, Marloes Levers, Liesbeth van Emst, Joost C. van Galen, Ad Geurts van Kessel, Roland P. Kuiper, Peter Hoogerbrugge, Frank N. van Leeuwen
Journal: Blood (2010)
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis
Authors: April W. Armstrong, Michael P. Siegel, Jerry Bagel, Erin E. Boh, Megan Buell, Kevin D. Cooper, Kristina Callis Duffin, Lawrence F. Eichenfield, Amit Garg, Joel M. Gelfand, Alice B. Gottlieb, John Y.M. Koo, Neil J. Korman, Gerald G. Krueger, Mark G. Lebwohl, Craig L. Leonardi, Arthur M. Mandelin, M. Alan Menter, Joseph F. Merola, David M. Pariser, Ronald B. Prussick, Caitriona Ryan, Kara N. Shah, Jeffrey M. Weinberg, MaryJane O.U. Williams, Jashin J. Wu, Paul S. Yamauchi, Abby S. Van Voorhees
Journal: Journal of the American Academy of Dermatology (2016)

An urgent need exists in the United States to establish treatment goals in psoriasis.We aim to establish defined treatment targets toward which clinicians and patients with psoriasis can strive to inform treatment decisions, reduce disease burden, and improve outcomes in practice.The National Psoriasis Foundation conducted a consensus-building study among psoriasis experts using the Delphi method. The process consisted of: (1) literature review, (2) pre-Delphi question selection and input from general dermatologists and patients, and (3) 4 Delphi rounds.A total of 25 psoriasis experts participated in the Delphi process. The most preferred instrument was body surface area (BSA). The most preferred time for evaluating patient response after starting new therapies was at 3 months. The acceptable response at 3 months postinitiation was either BSA 3% or less or BSA improvement 75% or more from baseline. The target response at 3 months postinitiation was BSA 1% or less. During the maintenance period, evaluation every 6 months was most preferred. The target response at every 6 months maintenance evaluation is BSA 1% or less.Although BSA is feasible in practice, it does not encompass health-related quality of life, costs, and risks of side effects.With defined treatment targets, clinicians and patients can regularly evaluate treatment responses and perform benefit-risk assessments of therapeutic options individualized to the patient.
A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.
Authors: Tom Fong, Kim Trinkaus, Douglas R. Adkins, Ravi Vij, Steven Devine, Michael Tomasson, Lawrence T. Goodnough, Timothy Graubert, Shalini Shenoy, John F. DiPersio, Hanna J. Khoury
Journal: Blood (2005)
INCB018424, a Selective JAK1/2 Inhibitor, Significantly Improves the Compromised Nutritional Status and Frank Cachexia in Patients with Myelofibrosis (MF).
Authors: Ruben A. Mesa, Srdan Verstovsek, Hagop M. Kantarjian, Animesh D. Pardanani, Steven Friedman, Robert Newton, Susan Erickson-Viitanen, Deborah Hunter, John Redman, Swamy Yeleswaram, Edward Bradley, Ayalew Tefferi
Journal: Blood (2008)
Brentuximab Vedotin (BV) Does Not Impair Autologous Peripheral Blood Stem Cell Mobilization and Collection in Refractory/Relapsed CD30+ Lymphoma Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplant (HDC-ASCT)
Authors: Manuel Afable, Paolo F. Caimi, Chitra Hosing, Marcos de Lima, Issa F. Khouri, Basem M. William, Yago Nieto, Brenda W. Cooper, Paolo Anderlini, Erica L Campagnaro, Stanton L. Gerson, Hillard M. Lazarus, Richard E. Champlin, Uday R. Popat
Journal: Blood (2014)
UK government’s autumn statement: no relief for NHS and social care in England
Authors: Chris Ham
Journal: BMJ (2016)

Staff have become shock absorbers in a system lacking resources to meet rising demands

If silence speaks volumes then this year’s autumn statement sent a deafening message to the NHS and its partners in social care. The decision of the chancellor of the exchequer, Philip Hammond, not to heed widespread calls for additional funding, especially for social care, reflects an uncertain outlook for the economy after the June referendum vote to leave the EU. Forecasts for economic growth have been revised downwards, and the timetable for eliminating the deficit in public finances has been extended. In the absence of a willingness to raise taxes, the chancellor was left with little room for manoeuvre.

The government’s inaction came despite speculation that local authorities would be given greater freedom to raise council tax to support a social care system that the usually cautious Care Quality Commission has described as being at a “tipping point.”1 Cuts in social care spending mean that 400 000 fewer older …
Endoscopic features of an adenoid cystic carcinoma of the esophagus: narrow-band imaging and dual focus magnification
Authors: Franck Bardou, Jérôme Rivory, Maud Robert, Diane Collet Benzaquen, Jean-François Fléjou, Thierry Ponchon, Mathieu Pioche
Journal: Endoscopy (2016)

Endoscopic examination with virtual chromoendoscopy is currently the best way to distinguish squamous cell carcinoma and adenocarcinoma in the esophagus [1] [2]. However, some unusual tumors such as adenoid cystic carcinoma can have atypical endoscopic features.
The Effect of Sofosbuvir Containing Regimes in Patients with HCV Genotype 3 Infection-A Scandinavian Real-Life Experience
Authors: O. Dalgard, O. Weiland, G. Noraberg, L. Karlsen, M. Lagging, L. Heggelund, M. Färkkilâ, N. Weiss, U. Balslev, E. Belard, A.L.h. Øvrehus, M.S. Kjaer, H. Krarup, B.T. Roege, S. Hallager, L. Madsen, N.M. Weiss
Journal: Journal of Hepatology (2016)
Comparative Analysis of SSEA4+ and SSEA4− Mesenchymal Stem Cells Derived From Wharton's Jelly of Umbilical Cord
Authors: Haiping He, Tokiko Nagamura-Inoue, Miki Yuzawa, Yuki Yamamoto, Hajime Tsunoda, Arinobu Tojo
Journal: Blood (2012)
Perifosine in Combination with Bortezomib and Dexamethasone Extends Progression-Free Survival and Overall Survival in Relapsed/Refractory Multiple Myeloma Patients Previously Treated with Bortezombib: Updated Phase I/II Trial Results.
Authors: Paul Richardson, Jeffrey Lee Wolf, Andrzej Jakubowiak, Jeffrey A. Zonder, Sagar Lonial, David H Irwin, Amrita Krishnan, John Densmore, Noopur Raje, Michael H. Bar, Robert L Schlossman, Irene Ghobrial, Nikhil C. Munshi, Thomas Martin, Jacob Laubach, Jeffrey P. Allerton, Teru Hideshima, Lesa Gardner, Peter Sportelli, Kenneth C. Anderson
Journal: Blood (2009)
In Vivo Efficacy of Peptide-Derived B Cell Receptor (BCR) Targeted Therapy In a Disseminated Burkitt′s Lymphoma Xenograft Modell
Authors: Claudia Wehr, Julia Schüler, Claudia Nitschke, Kerstin Klingner, Fabian Müller, Heinz-Herbert Fiebig, Roland H. Mertelsmann, Martin Trepel
Journal: Blood (2010)
Supporting Family Decision Makers for Nursing Home Residents
Authors: Jennifer L. Carnahan, Nicole R. Fowler, Kathleen T. Unroe
Journal: JAMA Internal Medicine (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
First-Line Treatment and Outcome of Elderly Patients with Primary Central Nervous System Lymphoma (PCNSL) – A Systematic Review and Individual Patient Data Meta-Analysis
Authors: Benjamin Kasenda, Andrés J.M. Ferreri, Emerenziana Maturano, Jacoline J.E.C. Bromberg, Herve Ghesquieres, Celine Ferlay, Jean-Yves Blay, Khe Hoang Xuan, Yasushi Okoshi, Shigeru Chiba, Kristina Fritsch, Antonio Omuro, Brian Patrick O'Neill, Osnat Bairey, Viktoria Gloy, Neera Bhatnagar, Stefan Haug, Susanne Rahner, Gerald Illerhaus, Matthias Briel
Journal: Blood (2012)
Hypermethylation of HOX Genes Is Associated with Longer Survival in Acute Myeloid Leukemia
Authors: Jaroslav Jelinek, Heike Kroeger, Rong He, Amanda Saraf, Samantha F Lau, Tuong-Van Nguyen, Michael W Thomas, Elizabeth J Shpall, Steven Kornblau, Carlos Bueso-Ramos, Hagop M Kantarjian, Jean-Pierre J Issa
Journal: Blood (2008)
Predictive Factors for All-Trans Retinoic Acid Related Differentiation Syndrome In Acute Promyelocytic Leukemia.
Authors: Houry Leblebjian, Anne McDonnell, J. Andrew Skirvin, Martha Wadleigh, Xiaopan Yao, Donna Neuberg, Sylvia Bartel, Daniel J DeAngelo, Richard M Stone
Journal: Blood (2010)
Dose-Intense BACOP for Treatment of High Risk Peripheral T-Cell NHL (PTCL)
Authors: Igor Aurer, Dino Dujmovic, Ivo Radman, Sandra Basic-Kinda, Damir Nemet, Ivana Ilic, Ranka Stern-Padovan, Fedor Santek, Dubravka Sertic
Journal: Blood (2010)
Prognostic Value of Cytogenetics in Patients with Acute Myeloid Leukemia Aged More Than 60 Years at Diagnosis: Identification of Subgroups Taking Benefit from Intensive Chemotherapy. Results from a Large Single Center Retrospective Study.
Authors: Nicolas Blin, Pascaline Talmant, Richard Garand, Francoise Accard, Philippe Moreau, Jean-Luc Harousseau, Herve Avet-Loiseau
Journal: Blood (2007)
Various Drugs with or without an Antisickling Effect in the In Vitro Tests Showed a Strong Antisickling Effect in the In Vivo Studies in Transgenic Sickle Mice.
Authors: Toshio Asakura, Osheiza Abdulmalik, Efe Iyamu, Qiukan Chen, Jisheng Yang, Donald J. Abraham, Martin K. Safo, Carlo Brugnara, Greg Evans
Journal: Blood (2005)
NPM-ALK Mediated Tyrosine Phosphorylation of ATP Citrate Lyase Regulates Lipid Metabolism and Promotes Oncogenesis of Anaplastic Large Cell Lymphoma
Authors: Johnvesly Basappa, Mahmoud A ElAzzouny, Delphine CM Rolland, Thirunavukkarasu Velusamy, Steven Hwang, Venkatesha Basrur, Kevin Conlon, Lili Zhao, Nathanael G. Bailey, Charles F Burant, Kojo SJ Elenitoba-Johnson, Megan S Lim
Journal: Blood (2015)
Human Telomerase Reverse Transcriptase (hTERT): A New Potential Prognostic Marker in AML?
Authors: Paolo Bernasconi, Catherine Klersy, Barbara Rocca, Celeste Calvello, Antonella Orlando, Marina Boni, Irene Dambruoso, Marianna Rossi, Paola Maria Cavigliano, Ilaria Giardini, Patrizia Zappasodi, Rita Zappatore, Marilena Caresana, Carlo Castagnola
Journal: Blood (2012)
IL-21-Mediated Generation of Human Regulatory B Cells Occurs Independently of CD40 Signaling
Authors: Bernd Jahrsdörfer, Christof Kaltenmeier, Ali Gawanbacht, Thamara Beyer, Catharina Schütz, Manfred Hönig, Frank Kirchhoff, Hubert Schrezenmeier
Journal: Blood (2014)
Single Amino Acid Substitution (Asp111Ala) in Coagulation Factor Va Causes Subunit Dissociation and Disrupted Calcium and Copper Binding.
Authors: Jina Song, Kimberley Talbot, Jeffrey Hewitt, Rodney M. Camire, Ross T.A. MacGillivray, Ed L. Pryzdial
Journal: Blood (2007)
Bortezomib, Melphalan, Prednisone and Thalidomide Followed by Maintenance with Bortezomib and Thalidomide (VMPT-VT) for Initial Treatment of Elderly Multiple Myeloma Patients: Updated Follow-up and Impact of Prognostic Factors
Authors: Antonio Palumbo, Sara Bringhen, Maide Cavalli, Roberto Ria, Massimo Offidani, Francesca Patriarca, Chiara Nozzoli, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Renato Zambello, Giuseppe Pietrantuono, Luca De Rosa, Anna Marina Liberati, Claudia Crippa, Giulia Perrone, Fabrizio Ciambelli, Angelo Michele Carella, Salvatore Palmieri, Milena Gilestro, Valeria Magarotto, Maria Teresa Petrucci, Pellegrino Musto, Gianluca Gaidano, Mario Boccadoro
Journal: Blood (2010)
Hsp90 at the Hub of Metabolic Homeostasis in Malignant B Cells
Authors: Nieves Calvo-Vidal, Jayeshkumar Patel, Jan Krumsiek, Thibault Dupont, Rebecca Goldstein, Shao Ning Yang, Ari Melnick, Gabriela Chiosis, Leandro Cerchietti
Journal: Blood (2014)
Prognositc Inpact of Tumor-Infiltrating FOXP3 + Regulatory T Cells in DLBCL Treated with R-CHOP
Authors: Naoe Goto, Hisashi Tsurumi, Yuhei Shibata, Ryoko Mabuchi, Nobuhiko Nakamura, Hiroshi Nakamura, Junichi Kitagawa, Nobuhiro Kanemura, Takeshi Hara, Hisataka Moriwaki
Journal: Blood (2012)
Intensified CHOP (ICHOP) +/− Rituximab in Primary Mediastinal Diffuse Large B Cell Lymphoma (PMBCL): The Role of Doxorubicin/Cyclophosphamide Dose-Intensity
Authors: Rita Mazza, Monica Demarco, Michele Spina, Massimo Magagnoli, Luca Castagna, Licia Siracusano, Laura Giordano, Umberto Tirelli, Armando Santoro, Monica Balzarotti
Journal: Blood (2008)
Prognostic Impact of MLL Partial Tandem Duplication in Acute Myeloid Leukemia of Intermediate Cytogenetic Risk: A Subgroup Analysis of Cetlam Protocol 2003 &amp; 2012
Authors: Marta Pratcorona, Ana Garrido, Salut Brunet, Jordi Esteve, María Camino Estivill, M. Paz Queipo De Llano, Susana Vives, Montserrat Arnan, David Gallardo, Mar Tormo, Antoni Garcia-Guiñon, Antonia Sampol, Olga Salamero, Josep Ma Martí, Joan Bargay, M Carmen Pedro, Montserrat Hoyos, Marina Diaz-Beya, Lourdes Escoda, Ramon Guàrdia, Josep Ribera, Jorge Sierra, Josep F. Nomdedeu
Journal: Blood (2015)
Apomorphine and Levallorphan Tartrate in Acute Poisonings
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial
Authors: Toni K. Choueiri, Susan Halabi, Ben L. Sanford, Olwen Hahn, M. Dror Michaelson, Meghara K. Walsh, Darren R. Feldman, Thomas Olencki, Joel Picus, Eric J. Small, Shaker Dakhil, Daniel J. George, Michael J. Morris
Journal: Journal of Clinical Oncology (2017)

Purpose Cabozantinib is an oral potent inhibitor of vascular endothelial growth factor receptor 2, MET, and AXL and is a standard second-line therapy for metastatic renal cell carcinoma (mRCC). This randomized phase II multicenter trial evaluated cabozantinib compared with sunitinib as first-line therapy in patients with mRCC. Patients and Methods Eligible patients had untreated clear cell mRCC and Eastern Cooperative Oncology Group performance status of 0 to 2 and were intermediate or poor risk per International Metastatic Renal Cell Carcinoma Database Consortium criteria. Patients were randomly assigned at a one-to-one ratio to cabozantinib (60 mg once per day) or sunitinib (50 mg once per day; 4 weeks on, 2 weeks off). Progression-free survival (PFS) was the primary end point. Objective response rate (ORR), overall survival, and safety were secondary end points. Results From July 2013 to April 2015, 157 patients were randomly assigned (cabozantinib, n = 79; sunitinib, n = 78). Compared with sunitinib, cabozantinib treatment significantly increased median PFS (8.2 v 5.6 months) and was associated with a 34% reduction in rate of progression or death (adjusted hazard ratio, 0.66; 95% CI, 0.46 to 0.95; one-sided P = .012). ORR was 33% (95% CI, 23% to 44%) for cabozantinib versus 12% (95% CI, 5.4% to 21%) for sunitinib. All-causality grade 3 or 4 adverse events were 67% for cabozantinib and 68% for sunitinib and included diarrhea (cabozantinib, 10% v sunitinib, 11%), fatigue (6% v 15%), hypertension (28% v 22%), palmar-plantar erythrodysesthesia (8% v 4%), and hematologic adverse events (3% v 22%). Conclusion Cabozantinib demonstrated a significant clinical benefit in PFS and ORR over standard-of-care sunitinib as first-line therapy in patients with intermediate- or poor-risk mRCC.
Evaluation of Leukemic Stem Cell Persistence in Chronic Myeloid Leukemia (CML) Patients in Complete Molecular Remission Induced by First Line TKI Therapies
Authors: Jean-Claude Chomel, Marie Laure Bonnet, Nathalie Sorel, Ivan Sloma, Alexis Proust, Annelise Bennaceur-Griscelli, Delphine Rea, Madalina Uzunov, Laurence Legros, Shanti Ame, Anne Marfaing-Koka, Agnès Guerci, Philippe Rousselot, Ali G Turhan
Journal: Blood (2012)
P0101 : Spectrum and short term outcome of renal impairment in cirrhosis
Authors: S. Vinit, A. Kumar, P. Sharma, R.K. Bansal, P. Tyagi, N. Bansal, V. Singla, M. Kumar, P. Ranjan, M.K. Sachdeva, A. Arora
Journal: Journal of Hepatology (2015)
Influence of Nanopolymers with Different End-Functionalities on Platelet Function and the Coagulation Cascade - An Ex-Vivo Study.
Authors: Meera Chitlur, Erin Ware, Sujata Kannan, Wendy Hollon, Steve Buck, I. Rajyalakshmi, Rangaramanujam Kannan, Indira Warrier, Madhvi Rajpurkar, Jeanne Lusher
Journal: Blood (2006)
Durable Complete Responses Following Therapy with Epratuzumab Plus Rituximab: Final Efficacy Results of a Multicenter Study in Recurrent Indolent Non-Hodgkin’s Lymphoma (NHL).
Authors: John P. Leonard, Stephen J. Schuster, Christos Emmanouilides, Felix Couture, Nick Teoh, William A. Wegener, David M. Goldenberg
Journal: Blood (2007)
Chronic Lymphocytic Leukemia, Detection of Five Significant Prognostic Genomic Aberrations by Interphase Two-Color Fluorescence in Situ Hybridization Analyses: a Study of 24 Patients with Clinical Follow-up Ranged From 7 to 120 Months.
Authors: Carlos Sergio Barragan, Silvia B. Hansson, Silvina A Cicchini, Monica Tamashiro, Pablo G Dinardo, David Veron
Journal: Blood (2009)
Phase I/II Trial of Bortezomib + CHOP-Rituximab in Diffuse Large B Cell (DLBCL) and Mantle Cell Lymphoma (MCL): Phase I Results.
Authors: John P. Leonard, Richard R. Furman, Ying-Kuen K. Cheung, Eric J. Feldman, Hearn J. Cho, Julie M. Vose, Gwen Nichols, Patricia W. Glynn, Maureen A. Joyce, Jamie Ketas, Jia Ruan, John Carew, Ruben Niesvizky, Ann LaCasce, Amy Chadburn, Ethel Cesarman, Morton Coleman
Journal: Blood (2005)
Pomalidomide Therapy in Anemic Patients with Myelofibrosis: Results from a Phase-2 Randomized Multicenter Study
Authors: Ayalew Tefferi, Srdan Verstovsek, Giani Barosi, Francesco Passamonti, Gail J. Roboz, Heinz Gisslinger, Ronald Paquette, Francisco Cervantes, Candido E. Rivera, H. Joachim Deeg, Juergen Thiele, Hans Michael Kvasnicka, James W. Vardiman, B. Nebiyou Bekele, Ruben A. Mesa, Robert P Gale, Hagop M Kantarjian
Journal: Blood (2008)
Autologous Stem Cell Transplantation in First Complete Remission May Not Extend Progression Free Survival in Patients with ALK-Negative Peripheral T Cell Lymphoma
Authors: Clinton Yam, Daniel J. Landsburg, Xinyi Lin, Anthony Mato, Jakub Svoboda, Alison Loren, Noelle Frey, Edward A. Stadtmauer, David Porter, Stephen J. Schuster, Sunita Dwivedy Nasta
Journal: Blood (2015)
Anti-IL-12/23 p40 Antibody Attenuates Chronic Graft Versus Host Disease Via Suppression of IFN-γ/IL-17-Producing Cells
Authors: Taiga Kuroi, Sachiyo Okamoto, Kyosuke Saeki, Yujin Kobayashi, Hisakazu Nishimori, Hideaki Fujiwara, Ken-ichi Matsuoka, Nobuharu Fujii, Eisei Kondo, Mitsune Tanimoto, Yoshinobu Maeda
Journal: Blood (2014)
Validation of the International Harmonization Project (IHP) Guidelines in Early Stage Hodgkin Lymphoma (HL) Treated with Adriamycin, Vinblastine and Gemcitabine (AVG) (CALGB 50203): Early Results.
Authors: Lale Kostakoglu, David J. Straus, Heiko Schöder, Ann S. LaCasce, Nancy L Bartlett, Nathan Hall, Jeffrey L Johnson, Sin-Ho Jung, George P. Canellos, Lawrence H Schwartz, Bruce D. Cheson
Journal: Blood (2008)
Safety and Feasibility of a Diagnostic Algorithm Combining Clinical Probability, D-Dimer and Ultrasonography in Suspected Upper Extremity Deep Vein Thrombosis: A Prospective Management Study
Authors: Ankie Kleinjan, Marcello Di Nisio, Jan Beyer-Westendorf, Benilde Cosmi, Giuseppe Camporese, Angelo Ghirarduzzi, Pieter W. Kamphuisen, Hans-Martin Otten, Ettore Porreca, Harry R. Büller
Journal: Blood (2012)
Clinically Significant Responses Achieved with Romidepsin in Treatment-Refractory Cutaneous T-Cell Lymphoma: Final Results from a Phase 2B, International, Multicenter, Registration Study
Authors: Youn Kim, Sean Whittaker, Marie France Demierre, Alain H Rook, Adam Lerner, Madeleine Duvic, Sunil Reddy, Ellen J Kim, Tadeusz Robak, Jürgen C Becker, Alexey Samtsov, William McCulloch, Archibald G Prentice
Journal: Blood (2008)
Effects of Amifostine and Fengling Polysaccharide on Proliferation and Chemoprotection of Human Granulocyte-Macrophage Progenitor Cells.
Authors: Bao-An Chen, Cheng-Yin Huang, Chui-Ping Li, Chong Gao, Jia-Hua Ding, Yun-Yu Sun, Fei Fei, Ning-Na Chen
Journal: Blood (2005)
Role of Hematopoietic-Specific Protein 1 (HS1) in Apoptosis in B-Chronic Lymphocytic Leukemia.
Authors: Livio Trentin, Antonella Contri, Anna Maria Brunati, Federica Frezzato, Martina Frasson, Anna Cabrelle, Samuela Carraro, Martina Semenzato, Anna Rita Gallelli, Lorenzo Pinna, Arianna Donella-Deana, Renato Zambello, Gianpietro Semenzato
Journal: Blood (2006)
The PPARß Activation Mechanism Which Suppresses the Constitutive NF-kB Activity in Human Myeloma Cell Lines.
Authors: Ken-ichiro Otsuyama, Jakia Amin, Saeid Abroun, Abul Islam, Karim Shamsasenjan, Shamim Mohd Iqbal, Michio M. Kawano
Journal: Blood (2007)
Diffuse MRI Pattern of Marrow Infiltration Correlates with Suppressed Bone Formation and Increased Incidence of Vertebral Fractures in Multiple Myeloma.
Authors: Evangelos Terpos, Lia A. Moulopoulos, Athanasios Anagnostopoulos, Efstathios Kastritis, Maria Roussou, Vangelis Eleftherakis-Papaiakovou, Despina Barmparousi, Charis Matsouka, Meletios A. Dimopoulos
Journal: Blood (2006)